vidarabine has been researched along with Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, Y; Fujimaki, K; Ishigatsubo, Y; Kanamori, H; Koharazawa, H; Takabayashi, M; Takasaki, H; Yamaji, S | 1 |
| Dalessio, DJ | 1 |
2 other study(ies) available for vidarabine and Myasthenia Gravis
| Article | Year |
|---|---|
Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Myasthenia Gravis; Purpura, Thrombocytopenic, Idiopathic; Rituximab; Salvage Therapy; Treatment Outcome; Vidarabine | 2005 |
Neurology.
Topics: Autoimmune Diseases; Central Nervous System Diseases; Cerebrovascular Circulation; Cerebrovascular Disorders; Encephalitis, Arbovirus; Humans; Myasthenia Gravis; Orbit; Vidarabine | 1978 |